{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T17:58:00Z","timestamp":1789408680291,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.vaccine.2006.12.012","type":"journal-article","created":{"date-parts":[[2006,12,28]],"date-time":"2006-12-28T07:06:58Z","timestamp":1167289618000},"page":"2244-2251","source":"Crossref","is-referenced-by-count":98,"title":["Multicenter comparative study of a new ELISA, PLATELIA\u2122 RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vaccinated people"],"prefix":"10.1016","volume":"25","author":[{"given":"M.","family":"Feyssaguet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Dacheux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Audry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Compoint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Morize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Blanchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Bourhy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2006.12.012_bib1","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2006.12.012_bib2","unstructured":"World Health Organization (W.H.O.). Expert consultation on rabies, 1st report. W.H.O. technical series 931. Geneva; 2005, 88 pp."},{"key":"10.1016\/j.vaccine.2006.12.012_bib3","series-title":"OIE manual of standards of diagnostic tests and vaccines","author":"Office International des Epizooties","year":"2000"},{"issue":"4","key":"10.1016\/j.vaccine.2006.12.012_bib4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1128\/JCM.36.4.1117-1121.1998","article-title":"Intravitam diagnosis of human rabies by PCR using saliva and cerebrospinal fluid","volume":"36","author":"Crepin","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2006.12.012_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4049\/jimmunol.110.1.269","article-title":"Antigenic properties of rabies virus components","volume":"110","author":"Wiktor","year":"1973","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.12.012_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0147-9571(82)90010-8","article-title":"The structural proteins of rabies virus","volume":"5","author":"Cox","year":"1982","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2006.12.012_bib7","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1099\/0022-1317-64-8-1649","article-title":"Rabies subunit vaccines","volume":"64","author":"Wunner","year":"1983","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2006.12.012_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/312163a0","article-title":"Expression of rabies virus glycoproteins from a recombinant vaccinia virus","volume":"312","author":"Kieny","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2006.12.012_bib9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1128\/IAI.16.3.754-759.1977","article-title":"Rabies virus glycoproteins. II. Biological and serological characterization","volume":"16","author":"Cox","year":"1977","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.12.012_bib10","first-page":"353","article-title":"Localisation of immunogenic domains on the rabies virus glycoprotein","volume":"136E","author":"Wunner","year":"1985","journal-title":"Ann Virol (Paris)"},{"issue":"4","key":"10.1016\/j.vaccine.2006.12.012_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.biologicals.2005.06.005","article-title":"The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays","volume":"33","author":"Moore","year":"2005","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2006.12.012_bib12","first-page":"535","article-title":"A rapid reproducible test for determining rabies neutralising antibody","volume":"48","author":"Smith","year":"1973","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2006.12.012_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0092-1157(75)90061-X","article-title":"Measurement of rabies antibody: comparison of the mouse neutralisation test (MNT) with the rapid fluorescent focus inhibition test (RFFIT)","volume":"3","author":"Louie","year":"1975","journal-title":"J Biol Stand"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.012_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0092-1157(79)80038-4","article-title":"A collaborative study on the testing of rabies immune globulin (human) by the mouse neutralization test (MNT) and the rapid fluorescent focus inhibition test (RFFIT)","volume":"7","author":"Fitzgerald","year":"1979","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2006.12.012_bib15","first-page":"99","article-title":"Comparative studies of two potency tests for antirabies antiserum: neutralisation test in mice (MNT) and rapide fluorescent focus inhibition test (RFFIT)","volume":"64","author":"Kurz","year":"1986","journal-title":"Dev Biol Stand"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.012_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","article-title":"Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody","volume":"212","author":"Cliquet","year":"1998","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2006.12.012_bib17","unstructured":"Bourhy H, Sureau P. M\u00e9thodes de laboratoire pour le diagnostic de la rage. Metodos de laboratorio para el diagnostico de la rabia. Laboratory methods for rabies diagnosis. Ed by Commission des Laboratoires de R\u00e9f\u00e9rence et d\u2019Expertise de l\u2019Institut Pasteur; 1991, 197 pp."},{"issue":"4","key":"10.1016\/j.vaccine.2006.12.012_bib18","first-page":"489","article-title":"Epreuve immunoenzymatique pour la d\u00e9tection rapide des anticorps anti-rabiques","volume":"128A","author":"Atanasiu","year":"1977","journal-title":"Ann Microbiol (Paris)"},{"issue":"8034","key":"10.1016\/j.vaccine.2006.12.012_bib19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0140-6736(77)90321-X","article-title":"Enzyme immunoassay for demonstration of rabies virus antibodies after immunization","volume":"2","author":"Thraenhart","year":"1977","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2006.12.012_bib20","first-page":"257","article-title":"Microm\u00e9thode immunoenzymatique de titrage des anticorps antirabiques: utilisation de la glycoprot\u00e9ine rabique et de la prot\u00e9ine A conjugu\u00e9e \u00e0 la peroxydase","volume":"130","author":"Atanasiu","year":"1979","journal-title":"Ann Microbiol (Paris)"},{"key":"10.1016\/j.vaccine.2006.12.012_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jmv.1890090107","article-title":"Enzyme-linked immunosorbent assay: a rapid reproducible test for the measurement of rabies antibody","volume":"9","author":"Nicholson","year":"1982","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2006.12.012_bib22","first-page":"207","article-title":"Use of an enzyme immunoassay with protein A for rabies antigen and antibody titration","volume":"46","author":"Atanasiu","year":"1980","journal-title":"Dev Biol Stand"},{"issue":"2","key":"10.1016\/j.vaccine.2006.12.012_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0092-1157(86)90027-2","article-title":"The influence of the type of immunosorbent on rabies antibody EIA; advantages of purified glycoprotein over whole virus","volume":"14","author":"Perrin","year":"1986","journal-title":"J Biol Stand"},{"issue":"5","key":"10.1016\/j.vaccine.2006.12.012_bib24","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1128\/JCM.27.5.899-902.1989","article-title":"Enzyme-linked immunosorbent assay for determination of antibodies to the envelope glycoprotein of rabies virus","volume":"27","author":"Grassi","year":"1989","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2006.12.012_bib25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0147-9571(82)90028-5","article-title":"Corr\u00e9lations entre l\u2019\u00e9preuve immuno-enzymatique, la s\u00e9roneutralisation et la r\u00e9duction de foyers fluorescents pour le titrage des anticorps rabiques","volume":"5","author":"Sureau","year":"1982","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2006.12.012_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/biol.1994.1036","article-title":"Calibration of a replacement preparation for the International Standard for Rabies Immunoglobulin","volume":"22","author":"Lyng","year":"1994","journal-title":"Biologicals"},{"issue":"8982","key":"10.1016\/j.vaccine.2006.12.012_bib27","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(95)91748-9","article-title":"Comparing methods of measurement: why plotting difference against standard method is misleading","volume":"346","author":"Bland","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.12.012_bib28","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1016\/j.vaccine.2005.10.015","article-title":"Preventing the incurable: Asian rabies experts advocate rabies control","volume":"16","author":"Dodet","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.12.012_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virusres.2006.02.011","article-title":"Collaborative study to evaluate a new ELISA test to monitor the effectiveness of rabies vaccination in domestic carnivores","volume":"120","author":"Servat","year":"2006","journal-title":"Virus Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06013296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06013296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T02:50:21Z","timestamp":1683687021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06013296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0264410X06013296"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.12.012","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}